Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: A preliminary report on an active regimen

被引：0
|
作者：
Georgoulias, V
Kourousis, C
Kakolyris, S
Androulakis, N
Dimopoulos, MA
Papadakis, E
Kotsakis, T
Vardakis, N
Kalbakis, K
Merambeliotakis, N
Hatzidaki, D
机构：
[1] UNIV CRETE, DEPT MED ONCOL, IRAKLION, GREECE
[2] UNIV ATHENS, DEPT CLIN THERAPEUT, ATHENS, GREECE
[3] SOTIRIA GEN HOSP CHEST DIS ATHENS, DEPT PULM MED 1, ATHENS, GREECE
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 66
页数：6
相关论文
共 50 条
  • [41] Low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer:: a phase II study
    Juan, O
    Albert, A
    Ordoño, F
    Casany, R
    Carañana, V
    Campos, JM
    Alberola, V
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (11) : 449 - 454
  • [42] Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer
    Ceresoli, GL
    Gregorc, V
    Cordio, S
    Bencardino, KB
    Schipani, S
    Cozzarini, C
    Bordonaro, R
    Villa, E
    LUNG CANCER, 2004, 44 (02) : 231 - 239
  • [43] Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer
    Reckamp, Karen L.
    CANCER LETTERS, 2012, 321 (02) : 101 - 109
  • [44] The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Tucker, Steven
    CURRENT DRUG TARGETS, 2010, 11 (01) : 58 - 60
  • [45] Biweekly paclitaxel as second-line treatment in advanced non-small cell lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group
    Vazquez-Estevez, S.
    Firvida, J.
    Huidobro, G.
    Leon, L.
    Lazaro, M.
    Salgado, M.
    Mel, J.
    Grande, C.
    Perez, E.
    Campos, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Second-line treatment with Gemcitabine and Vinorelbine in non-small cell lung cancer (NSCLC): A retrospective analysis of 46 patients
    Czerny, P
    Treutler, D
    Schneider, CP
    Bonnet, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 275 - 278
  • [47] Gemcitabine Plus Vinorelbine as the Second-Line Treatment and Beyond in Elderly Patients with Platinum-Pretreated Advanced Non-Small Cell Lung Cancer
    Go, Se-Il
    Lee, Won Sup
    Lee, Gyeong-Won
    Kang, Jung Hun
    Kang, Myoung Hee
    Song, Haa-Na
    Lee, Anna
    Lee, Un Seok
    Choi, Hye Jung
    Kim, Hoon-Gu
    CHEMOTHERAPY, 2014, 60 (04) : 267 - 273
  • [48] Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer
    Rosati, G
    Rossi, A
    Nicolella, G
    Panza, N
    ANTICANCER RESEARCH, 2000, 20 (3B) : 2229 - 2233
  • [49] Second line chemotherapy with weekly paclitaxel in advanced non-small cell lung cancer.
    Leon, L
    Cueva, J
    Cudel, T
    Calvo, M
    Graña, B
    Padín, E
    Candamio, S
    Barón, F
    López, R
    ANNALS OF ONCOLOGY, 2000, 11 : 121 - 121
  • [50] Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer
    Hoang, Tien
    Kim, KyungMann
    Merchant, Joseph
    Traynor, Anne M.
    McGovern, James
    Oettel, Kurt R.
    Sanchez, Fredrico A.
    Ahuja, Harish G.
    Hensing, Thomas A.
    Larson, Martha
    Schiller, Joan H.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 218 - 225
12345